Search Result "177Lu"

A Potencial Theranostic Agent for EGF-R Expression Tumors: 177Lu- DOTA-Nimotuzumab

Journal: Current Radiopharmaceuticals
Volume: 5 Issue: 4 Year: 2012 Page: 318-324
Author(s): Victoria Calzada,Xiuli Zhang,Marcelo Fernandez,Arlhee Diaz-Miqueli,Normando Iznaga-Escobar,Susan L. Deutscher,Henia Balter,Thomas P. Quinn,Pablo Cabral

Biodistribution and Dosimetry of 177Lu-tetulomab, a New Radioimmunoconjugate for Treatment of Non-Hodgkin Lymphoma

Journal: Current Radiopharmaceuticals
Volume: 6 Issue: 1 Year: 2013 Page: 20-27
Author(s): Ada H. V. Repetto-Llamazares, Roy H. Larsen, Camilla Mollatt, Michael Lassmann, Jostein Dahle

Research Article

177Lu-DOTA-Bevacizumab: Radioimmunotherapy Agent for Melanoma

Journal: Current Radiopharmaceuticals
Volume: 10 Issue: 1 Year: 2017 Page: 21-28
Author(s): Ximena Camacho,Victoria Calzada,Marcelo Fernandez,Omar Alonso,Roger Chammas,Eloisa Riva,Juan Pablo Gambini,Pablo Cabral

[177Lu]-DOTA0-Tyr3-Octreotate: A Potential Targeted Radiotherapeutic for the Treatment of Medulloblastoma

Journal: Current Radiopharmaceuticals
Volume: 3 Issue: 1 Year: 2010 Page: 29-36
Author(s): Ganesan Vaidyanathan, Donna J. Affleck, Xiao-Guang Zhao, Stephen T. Keir, Michael R. Zalutsky

Studies on Efficacy of a Novel 177Lu-Labeled Porphyrin Derivative in Regression of Tumors in Mouse Model

Journal: Current Radiopharmaceuticals
Volume: 4 Issue: 2 Year: 2011 Page: 150-160
Author(s): Haladhar D. Sarma, Tapas Das, Sharmila Banerjee, Meera Venkatesh, Pandit B. Vidyasagar, Kaushala P. Mishra

Research Article

Effect of Number of Bifunctional Chelating Agents on the Pharmacokinetics and Immunoreactivity of 177Lu-labeled Rituximab: A Systemic Study

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 18 Issue: 1 Year: 2018 Page: 146-153
Author(s): Mohini Guleria,Tapas Das,Chandan Kumar,Rohit Sharma,Jeyachitra Amirdhanayagam,Haladhar D. Sarma,Ashutosh Dash

Radiomics Analysis of 177Lu-PSMA I&T Radioligand Therapy Dosimetry in a Castration Resistant Metastatic Prostate Cancer Patient

Ebook: The Evolution of Radionanotargeting towards Clinical Precision Oncology: A Festschrift in Honor of Kalevi Kairemo
Volume: 1 Year: 2022
Author(s):
Doi: 10.2174/9781681088655122010039

Review Article

Real-World Evidence of Clinical Outcomes in Precision Radionuclide Oncology: The NIGHTCAP Study of 177Lu-PSMA in Metastatic Prostate Cancer

Journal: Current Pharmaceutical Design
Volume: 26 Issue: 31 Year: 2020 Page: 3799-3803
Author(s): J. Harvey Turner

Estimation of specific activity of 177Lu by `saturation assay` principle using DOTA as ligand

Journal: Current Radiopharmaceuticals
Volume: 8 Issue: 2 Year: 2015 Page: 123-128
Author(s): Ambikalmajan M.R. Pillai,Sudipta Chakraborty,Tapas Das

Research Article

Synthesis and Ready to Use Kit Formulation of EDTMP for thePreparation of 177Lu-EDTMP as a Bone Palliation Radiopharmaceutical

Journal: Current Radiopharmaceuticals
Volume: 16 Issue: 1 Year: 2023 Page: 38-43
Author(s):

Previous   Next

Go To   Results 1 - 1 of 171

Apply Filters

Volume Years
Article Type
Publication Title
Subject Title

Content Type


© 2024 Bentham Science Publishers | Privacy Policy